尿液分析在预测ANCA相关血管炎肾脏复发风险中的价值
本研究为对两项随机安慰剂对照试验的事后分析,纳入149例经诱导治疗6个月达缓解的ANCA相关血管炎合并活动性肾小球肾炎患者。结果显示,持续血尿(而非持续蛋白尿)与肾脏复发风险显著升高独立相关,且血尿累积持续时间越长,复发风险越高。
要点
- 持续血尿是ANCA相关血管炎患者肾脏复发的显著预测因子。
- 持续蛋白尿与肾脏复发无显著关联。
- 血尿累积持续时间每增加1个月,复发风险增加8%。
核心结论
- 在经诱导治疗达缓解的ANCA相关血管炎合并肾脏受累患者中,持续血尿(而非蛋白尿)是未来肾脏复发的显著预测因素。
研究设计与样本
- 对两项随机、安慰剂对照临床试验的事后分析,纳入149例有活动性肾小球肾炎、ANCA阳性且第6个月达缓解的ANCA相关血管炎患者。
主要发现
- 42%的患者持续血尿超过6个月,43%的患者持续蛋白尿超过6个月。
- 持续血尿与复发风险显著升高相关(校正后亚分布风险比3.99;95%CI 1.20至13.25;P=0.02)。
- 持续蛋白尿与肾脏复发无显著关联(亚分布风险比1.44;95%CI 0.47至4.42;P=0.53)。
- 血尿累积持续时间每增加1个月,肾脏复发风险显著升高(校正后亚分布风险比1.08;95%CI 1.03至1.12;P<0.01)。
- 肾脏复发的中位时间为22个月。
临床怎么用
- 对达缓解的ANCA相关血管炎合并肾脏受累患者,应关注持续血尿以评估肾脏复发风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVES: The significance of persistent hematuria or proteinuria in patients with ANCA-associated vasculitis who are otherwise in clinical remission is unclear. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: A post hoc analysis was conducted using participants enrolled in two randomized, placebo-controlled clinical trials who had active GN due to ANCA-associated vasculitis, had positive ANCA, and achieved remission by month 6. Dipstick and microscopic urinalyses were performed at each visit. Persistent hematuria or proteinuria for at least 6 months and the cumulative duration of hematuria were examined. Renal relapse was defined as new or worsening red blood cell casts and/or worsening kidney function according to the Birmingham Vasculitis Activity Score for Granulomatosis with Polyangiitis. RESULTS: There were 149 patients included in this study: 42% had persistent hematuria, and 43% had persistent proteinuria beyond 6 months. Persistent hematuria was associated with a significantly higher risk of relapse, even after adjusting for potential confounders (subdistribution hazard ratio, 3.99; 95% confidence interval, 1.20 to 13.25; P=0.02); persistent proteinuria was not associated with renal relapse (subdistribution hazard ratio, 1.44; 95% confidence interval, 0.47 to 4.42; P=0.53). Furthermore, greater cumulative duration of hematuria was significantly associated with a higher risk of renal relapse (adjusted subdistribution hazard ratio, 1.08 per each month; 95% confidence interval, 1.03 to 1.12; P<0.01). The median time to renal relapse was 22 months. CONCLUSIONS: In patients with ANCA-associated vasculitis and kidney involvement who achieve remission after induction therapy, the presence of persistent hematuria, but not proteinuria, is a significant predictor of future renal relapse.
引用
- Rhee RL, Davis JC, Ding L, et al. The Utility of Urinalysis in Determining the Risk of Renal Relapse in ANCA-Associated Vasculitis. Clin J Am Soc Nephrol. 2018. PMID: 29371340. doi:10.2215/CJN.04160417
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。